Ameritas Advisory Services’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232 Buy
+12
New +$202 ﹤0.01% 1885
2025
Q3
Sell
-13
Closed -$293 2623
2025
Q2
$293 Buy
+13
New +$320 ﹤0.01% 2735

Other funds holding MRNY

Ameritas Advisory Services's MRNY Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026: 12 shares worth $232. The stake represents ﹤0.01% of the portfolio and ranks #1885 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in MRNY as recently as Q2 2025.

Ameritas Advisory Services first reported a position in MRNY in Q2 2025 and has held it in 2 quarters since. The position peaked at $293 in Q2 2025. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Ameritas Advisory Services held 12 shares of YieldMax MRNA Option Income Strategy ETF worth $232 as of Q2 2026.
  • YieldMax MRNA Option Income Strategy ETF was a new Ameritas Advisory Services position in Q2 2026.
  • YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1885 holding.
  • Ameritas Advisory Services first reported a position in YieldMax MRNA Option Income Strategy ETF in Q2 2025 and has held it in 2 quarters since.
  • Ameritas Advisory Services's YieldMax MRNA Option Income Strategy ETF position peaked at $293 in Q2 2025.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.